Scholarlink

<p>Somatic variant calling algorithms typically detect mutations in cancer genomes by comparing sequence data from a tumor sample against a matched normal sample. However, matched normal samples are often unavailable in clinical diagnostics or retrospective analyses of archival tumor samples in biobanks, compromising variant calling accuracy due to the difficulty in distinguishing somatic mutations from germline mutations or sequencing artifacts. Here, we introduce VarNet-T, an end-to-end weakly supervised deep learning framework for accurately identifying somatic variants from aligned tumor reads without a matched normal sample. VarNet-T is trained using millions of high-confidence variants and benchmarked using public datasets, demonstrating 20-33% performance improvement over existing methods. We assess the accuracy of tumor mutation burden (TMB) estimation on 1000 tumor samples spanning 10 solid cancer types. Compared to existing methods, VarNet-T demonstrates &gt;3x higher accuracy in TMB-high status classification, suggesting significant potential to improve patient selection for immunotherapy. Overall, the improved accuracy of VarNet-T has the potential to enhance the utility of tumor-only sequencing in cancer research and clinical molecular diagnostics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Improved tumor-only variant calling and mutation burden estimation with VarNet-T

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月9日

查看全文
  • Kiran Krishnamachari,
  • Huu An Bui Nguyen,
  • Sinem Kadioglu,
  • Jet Ong Tze,
  • Anders Jacobsen Skanderup

摘要

Somatic variant calling algorithms typically detect mutations in cancer genomes by comparing sequence data from a tumor sample against a matched normal sample. However, matched normal samples are often unavailable in clinical diagnostics or retrospective analyses of archival tumor samples in biobanks, compromising variant calling accuracy due to the difficulty in distinguishing somatic mutations from germline mutations or sequencing artifacts. Here, we introduce VarNet-T, an end-to-end weakly supervised deep learning framework for accurately identifying somatic variants from aligned tumor reads without a matched normal sample. VarNet-T is trained using millions of high-confidence variants and benchmarked using public datasets, demonstrating 20-33% performance improvement over existing methods. We assess the accuracy of tumor mutation burden (TMB) estimation on 1000 tumor samples spanning 10 solid cancer types. Compared to existing methods, VarNet-T demonstrates >3x higher accuracy in TMB-high status classification, suggesting significant potential to improve patient selection for immunotherapy. Overall, the improved accuracy of VarNet-T has the potential to enhance the utility of tumor-only sequencing in cancer research and clinical molecular diagnostics.